Nguyen Linh, Le Yen-Chi L, Reygaerts Hannah, Johnson Todd R, Soutullo Cesar A
Center for Population Health Management & Quality, Department of Healthcare Transformation Initiatives, The University of Texas Health Science Center at Houston, USA.
UTHealth Houston McWilliams School of Biomedical Informatics, TX, USA.
J Atten Disord. 2025 Oct;29(12):1039-1053. doi: 10.1177/10870547251336852. Epub 2025 May 13.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common behavioral health condition that impacts 5% to 8% of children and 2.5% of adults worldwide. The symptoms of ADHD are effectively managed with medication, yet patients with ADHD may inconsistently take their medication. We assessed medication adherence among patients with ADHD and identified factors associated with medication adherence that may be utilized to optimize adherence.
This is a retrospective, observational study among patients aged 4 years and older with a diagnosis of ADHD at primary care and multispecialty outpatient clinics during May 2021 to May 2023. We assessed sociodemographic characteristics, stratified by medication adherence status (Percentage of Days Covered ≥ 80%) using simple proportion, Student's -test, and Chi-square test. We conducted univariable and multivariable logistic regression analyses to assess potential medication adherence factors, including sociodemographic characteristics, depressive symptoms, suicide risk, health service utilization, and social determinants of health (SDOH).
We found 7,661 patients diagnosed with ADHD, with a mean () age of 21.8 (14.8) years. The ADHD prevalence was 5.5% for patients aged 4 to 12, 4.4% for 13 to 17, and 0.8% for 18+ years old. Most patients were male (56.9%), non-Hispanic White (37.6%), and privately insured (55.1%). Among these patients, only 4,242 (55.4%) were treated with medication. Among 4,011 patients with medication adherence information, the average adherence rate was 56%, and only 1,113 patients (27.5%) met our threshold for adherence to ADHD treatment (80%). Adherence was positively associated with being adults, having more BH and PCP visits, and negatively associated with racial and ethnic minorities and more severe depressive symptoms.
Only half of patients with ADHD were treated with medication. Of those treated, less than a third adhered to medication. Age, race and ethnicity, depressive symptoms, and BH and PCP visits were statistically associated with medication adherence. Healthcare providers may need to address factors such as coexisting depressive symptoms, and unmet SDOH needs to improve medication adherence among patients with ADHD. Also, patients reaching adolescence may need enhanced medication management.
注意力缺陷多动障碍(ADHD)是一种常见的行为健康状况,影响着全球5%至8%的儿童和2.5%的成年人。ADHD的症状可通过药物有效控制,但ADHD患者可能会不定期服药。我们评估了ADHD患者的药物依从性,并确定了与药物依从性相关的因素,这些因素可用于优化依从性。
这是一项回顾性观察研究,研究对象为2021年5月至2023年5月期间在初级保健和多专科门诊诊所被诊断为ADHD的4岁及以上患者。我们评估了社会人口学特征,按药物依从性状态(覆盖天数百分比≥80%)分层,使用简单比例、学生t检验和卡方检验。我们进行了单变量和多变量逻辑回归分析,以评估潜在的药物依从性因素,包括社会人口学特征、抑郁症状、自杀风险、医疗服务利用情况以及健康的社会决定因素(SDOH)。
我们发现7661名被诊断为ADHD的患者,平均()年龄为21.8(14.8)岁。4至12岁患者的ADHD患病率为5.5%,13至17岁为4.4%,18岁及以上为0.8%。大多数患者为男性(56.9%)、非西班牙裔白人(37.6%)且有私人保险(55.1%)。在这些患者中,只有4242名(55.4%)接受了药物治疗。在4011名有药物依从性信息的患者中,平均依从率为56%,只有1113名患者(27.5%)达到我们的ADHD治疗依从性阈值(80%)。依从性与成年、更多的行为健康(BH)和初级保健医生(PCP)就诊次数呈正相关,与少数族裔和更严重的抑郁症状呈负相关。
只有一半的ADHD患者接受了药物治疗。在接受治疗的患者中,不到三分之一坚持服药。年龄、种族和民族、抑郁症状以及BH和PCP就诊次数在统计学上与药物依从性相关。医疗保健提供者可能需要解决诸如并存的抑郁症状以及未满足的SDOH需求等因素,以提高ADHD患者的药物依从性。此外,进入青春期的患者可能需要加强药物管理。